Loading chart…
CLOSED
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States.
Sakar Healthcare Limited (SAKAR) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The SAKAR share price is ₹1,036.50 (+6.31% today), with a market capitalisation of ₹23B and a price-to-earnings (P/E) ratio of 77.6. MarketRipple tracks the SAKAR investment thesis, the ripple-chain impact of market events on Sakar Healthcare Limited, and the Healthcare sector outlook.
Open
₹1,024.00
High
₹1,059.70
Low
₹998.85
Prev. Close
₹975.00
52W High
₹1,229.85
52W Low
₹352.50
Day range
₹998.85–₹1,059.70
52-week range
₹352.50–₹1,229.85
Volume
121K
P/E
77.6
ROE
13.2%
D/E
0.22
Margin
14.2%
Sakar Healthcare Limited (NSE: SAKAR) is currently trading at ₹1,036.50 (+6.31%).
Sakar Healthcare Limited's market capitalization is ₹23B.
Sakar Healthcare Limited's price-to-earnings (P/E) ratio is 77.6.
Sakar Healthcare Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Sakar Healthcare Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.